Clinical trial

DIVA Study - A Study of Different Regimens of Intravenous Administration of…

NCT00048074 · Hoffmann-La Roche, Industry · Completed

Key facts

NCT number NCT00048074
Title DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
Official title A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
Lead sponsor Hoffmann-La Roche, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Post Menopausal Osteoporosis
Intervention type Drug
Interventions ibandronate [Bonviva/Boniva]
Enrollment 1,395
Start date Jun 1, 2002
Primary completion May 1, 2005
Completion May 1, 2005
First posted Oct 25, 2002
Last update posted Feb 3, 2016
Countries Australia, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Italy, Mexico, Norway, Poland and 4 more

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies